Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
about
The detection, treatment, and biology of epithelial ovarian cancerCell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisCharacterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatmentTargeting insulin and insulin-like growth factor pathways in epithelial ovarian cancerHtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancerSecreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancersOvarian cancer: opportunity for targeted therapy.Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.The insulin and igf-I pathway in endocrine glands carcinogenesisClinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.The peritoneal tumour microenvironment of high-grade serous ovarian cancer.Ovarian cancer: emerging concept on cancer stem cells.Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancerMicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.Antisense oligonucleotide suppression of human IGF-1R inhibits the growth and survival of in vitro cultured epithelial ovarian cancer cells.Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.microRNA and Ovarian Cancer.Adenovirus type 12 E1B 55-kilodalton oncoprotein promotes p53-mediated apoptotic response of ovarian cancer to cisplatin.Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression.Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells.6-Acetoxy Cyperene, a Patchoulane-type Sesquiterpene Isolated from Cyperus rotundus Rhizomes Induces Caspase-dependent Apoptosis in Human Ovarian Cancer Cells.Metformin and epithelial ovarian cancer therapeutics.MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.
P2860
Q21198791-4D2B04DE-E893-46E6-8A3E-395EF0F87752Q26851836-24A36BA8-84D0-418C-AD81-907FE89637B1Q28537709-B6FD9219-F9CF-4454-A600-D1A16B67F3C9Q33581021-53DB1A33-C2C3-4840-85F8-A72C9C7A2506Q33841141-9724BF0C-48CB-4E27-BE6D-A5C91EF6D295Q34024735-B02D7077-06CF-4981-A508-41C7420E8A3BQ34435134-384EFD41-DB8F-40E0-AD50-30BBF082C96CQ35659945-9D2B5FB6-86D5-4C5C-99A1-C127C167E1FEQ35709343-58C75CD7-9003-4E23-88BC-08D980FB6167Q36178421-FBB578C3-126B-41AE-9A66-FE24CCD57440Q36320168-69C8713C-D775-4FC5-93CE-ACB47729AA7AQ36341214-0284724F-5C4F-49CD-982C-675026E69F74Q36719074-CBC5C8EA-A159-4BAB-9093-F06EA45ADA92Q36975266-5746684A-3080-4E19-884B-32826C42C7F7Q37007099-C2C36D75-5289-4A55-8014-EE8AF2F5AEB4Q37123465-9BD1B762-E3D9-4996-BB43-AEEDF41C93EFQ37295716-41886FFD-0477-466E-98F1-56250C3D18E0Q37365005-32D86689-5225-4A6F-A031-8A2C665B52DEQ37372615-3F85685B-C16D-418F-B459-B57F3BA9E59FQ38667018-C88F68F7-A48E-42CB-9721-8ABF80FD040FQ38893456-F23E064C-D424-46C0-A719-A28C6107FF81Q39205696-1119AE7A-217D-402D-899A-710B1C26420AQ39616516-E492B645-5D47-4E12-B8F0-6F62764035B7Q39618964-A6DB739E-85DF-4CCC-B49C-ACC3C499C15EQ40849205-C4F51107-A29A-4EAC-AE62-A38FFA083079Q52925310-C2982138-9AD4-43DC-BBFD-A139B2CAC6DAQ55418376-A97A503A-27FD-4DF6-B58E-BA9F00A2DA1C
P2860
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
@en
type
label
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
@en
prefLabel
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
@en
P2093
P2860
P356
P1476
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer
@en
P2093
Debra A Bell
Gary L Keeney
Lynn C Hartmann
Viji Shridhar
P2860
P304
P356
10.1002/JCB.21552
P577
2007-12-01T00:00:00Z